Targeting of Pseudomonas aeruginosa in the bloodstream with bispecific monoclonal antibodies

Journal of Immunology

Volumn 167, Issue 4, 2001, Pages 2240-2249

  Lindorfer, M A ^a   Nardin, A ^a   Foley, P L ^a   Solga, M D ^a   Bankovich, A J ^a   Martin, E N ^a   Henderson, A L ^a   Price, C W ^a   Gyimesi, E ^a   Wozencraft, C P ^a   Goldberg, J B ^a   Sutherland, W M ^a   Taylor, R P ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; COMPLEMENT; COMPLEMENT RECEPTOR; CYTOKINE; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ARTICLE; CONTROLLED STUDY; GRAM NEGATIVE INFECTION; IMMUNOMODULATION; INFECTION RESISTANCE; MONKEY; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

EID: 0035882036     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.4.2240     Document Type: Article

References (60)

1. A quantitative analysis of the interactions of anti-pneumococcal antibody and complement in experimental pneumococcal bacteremia
2. Choice of bacteria in animal models of sepsis
3. Innate immunity
4. Recognition of Gram-negative bacteria and endotoxin by the innate immune system
5. Control of early viral and bacterial distribution and disease by natural antibodies
6. The immune-adherence phenomenon: An immunologically specific reaction between microorganisms and erythrocytes leading to enhanced phagocytosis
7. Primate erythrocyte-immune complex-clearing mechanism
8. Bispecific monoclonal antibody complexes facilitate erythrocyte binding and liver clearance of a prototype particulate pathogen in a monkey model
9. Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyte
10. An in vitro study of some mechanisms of antigen uptake by cells
11. Escherichia coli bound to the primate erythrocyte complement receptor via bispecific monoclonal antibodies are transferred to and phagocytosed by human monocytes in an in vitro model
12. Bispecific monoclonal antibodies mediate binding of dengue virus to erythrocytes in a monkey model of passive viremia
13. Use of heteropolymeric monoclonal antibodies to attach antigens to the C3b receptor of human erythrocytes: A potential therapeutic treatment
14. Cross-linked bispecific monoclonal antibody heteropolymers facilitate the clearance of human IgM from the circulation of squirrel monkeys
15. Bispecific monoclonal antibody complexes bound to primate erythrocyte CR1 facilitate virus clearance in a monkey model
16. How are immune complexes bound to the primate erythrocyte complement receptor transferred to acceptor phagocytic cells?
17. 1 on the adult respiratory distress syndrome in septic primates
18. Endotoxin and cytokine profile in plasma of baboons challenged with lethal and sublethal Escherichia coli
19. Endogenous modulators of TNF and IL-1 response are under partial control of TNF in baboon bacteremia
20. The endothelial cell protein C receptor aids in host defense against Escherichia coli sepsis
21. Infusion of bispecific monoclonal antibody complexes into monkeys provides immunologic protection against later challenge with a model pathogen
22. Antigen-based heteropolymers: A potential therapy for binding and clearing autoantibodies via erythrocyte CR1
23. Genomic mapping of Pseudomonas, aeruginosa PAO
24. Monoclonal antibodies to oncoproteins
25. Production of bispecific antibodies
26. Green fluorescent protein as a marker for Pseudomonas spp.
27. Transformation of Pseudomonas aeruginosa by electroporation
28. Gene transfer in Gram-negative bacteria
29. Cobra venom factor stimulates anti-α-galactose antibody production in baboons
30. Anesthesia and analgesia in nonhuman primates
31. Evidence for the distinct intracellular pools of receptors for C3b and C3bi in human neutrophils
32. Quantitative analyses of the binding of soluble complement-fixing antibody/dsDNA immune complexes to CR1 on human red blood cells
33. Serial quantitation of endotoxemia and bacteremia during therapy for Gram-negative bacterial sepsis
34. Gram-negative bacteremia. III. Reassessment of etiology, epidemiology and ecology in 612 patients
35. Strategies for the treatment of sepsis
36. Animal models of sepsis and shock: A review and lessons learned
37. Structure-function relationships of bacterial endotoxins: Contribution to microbial sepsis
38. Cytokine appearance in human endotoxemia and primate bacteremia
39. Release of leukemia inhibitory factor in primate sepsis
40. Regulation of tumor necrosis factor production by adrenaline and b-adrenergic agonists
41. Epinephrine inhibits TNF-α and potentiates IL-10 production during human endotoxemia
42. Epinephrine exerts anticoagulant effects during human endotoxemia
43. A bispecific dsDNA X monoclonal antibody construct for clearance of anti-dsDNA IgG in systemic lupus erythematosus
44. Characterization of the human complement (C3b) receptor with a fluid phase C3b dimer
45. Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21)
46. Biotinylation of monoclonal antibodies prevents their ability to activate the classical pathway of complement
47. Complement-mediated killing of microtumors in vitro
48. The role of complement and complement receptors in induction and regulation of immunity
49. Characterization and affinity isolation of xenoreactive human natural antibodies
50. The clinical significance of positive blood cultures in the 1990s: A prospective comprehensive evaluation of microbiology, epidemiology, and outcome of bacteremia and fungemia in adults
51. In vivo and in vitro studies of the binding of antibody/dsDNA immune complexes to rabbit and guinea pig platelets
52. Immune adherence and the processing of soluble complement-fixing antibody/DNA immune complexes in mice
53. Transfer of immune complexes from erythrocyte CR1 to mouse macrophages
54. Pathogenesis of septic shock in Pseudomonas aeruginosa pneumonia
55. Protease IV, a unique extracellular protease and virulence factor from Pseudomonas aeruginosa
56. The importance of a LPS-initiated, cytokine-mediated host defense mechanism in mice against extraintestinally invasive Escherichia coli
57. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene
58. Control of lipopolysaccharide (LPS) binding and LPS-induced TNF secretion in human peripheral blood monocytes
59. Dual effects of LPS antibodies on cellular uptake of LPS and LPS-induced proinflammatory functions
60. Mechanisms of phagocytosis in macrophages